{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:09:56Z","timestamp":1782551396865,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clineu-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.clineuro.2015.01.029","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T10:05:33Z","timestamp":1423303533000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5133-6327","authenticated-orcid":false,"given":"Corrado","family":"Iaccarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Torricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cerasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pisanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Froio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pellegrino","family":"Crafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"D'Abbiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Michiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghadirpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Servadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (3)","key":"10.1016\/j.clineuro.2015.01.029_bib0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3171\/2010.4.JNS091340","article-title":"Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article","volume":"114","author":"Chaichana","year":"2011","journal-title":"J Neurosurg"},{"issue":"August (15)","key":"10.1016\/j.clineuro.2015.01.029_bib0100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnci\/dji204","article-title":"Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene","volume":"97","author":"Chen","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"July (1)","key":"10.1016\/j.clineuro.2015.01.029_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1227\/00006123-198707000-00005","article-title":"Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection","volume":"21","author":"Ciric","year":"1987","journal-title":"Neurosurgery"},{"issue":"January (1)","key":"10.1016\/j.clineuro.2015.01.029_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","article-title":"Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981\/CE.3","volume":"9","author":"Gorlia","year":"2008","journal-title":"Lancet Oncol"},{"issue":"September (25)","key":"10.1016\/j.clineuro.2015.01.029_bib0115","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","article-title":"Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity","volume":"26","author":"Hegi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"March (10)","key":"10.1016\/j.clineuro.2015.01.029_bib0120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"issue":"July (7)","key":"10.1016\/j.clineuro.2015.01.029_bib0125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00701-010-0639-0","article-title":"Analysis of MGMT promoter methylation status on intraoperative fresh tissue section from frameless neuronavigation needle biopsy: a preliminary study of ten patients","volume":"152","author":"Iaccarino","year":"2010","journal-title":"Acta Neurochir (Wien)"},{"issue":"May (3)","key":"10.1016\/j.clineuro.2015.01.029_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11060-009-0031-1","article-title":"Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods","volume":"97","author":"Karayan-Tapon","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.clineuro.2015.01.029_bib0135","doi-asserted-by":"crossref","first-page":"634e56","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"issue":"August (2)","key":"10.1016\/j.clineuro.2015.01.029_bib0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J Neurosurg"},{"issue":"August (2)","key":"10.1016\/j.clineuro.2015.01.029_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"July (7)","key":"10.1016\/j.clineuro.2015.01.029_bib0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"issue":"May (5)","key":"10.1016\/j.clineuro.2015.01.029_bib0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"March (10)","key":"10.1016\/j.clineuro.2015.01.029_bib0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"April (4)","key":"10.1016\/j.clineuro.2015.01.029_bib0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.2010.214593","article-title":"Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide","volume":"82","author":"Thon","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2015.01.029_bib0170","series-title":"Center for Drug Evaluation and Research. Guidance for industry clinical trial endpoints for the approval of cancer drugs and biologics","author":"U.S. Food and Drug Administration","year":"2004"},{"issue":"July (5)","key":"10.1016\/j.clineuro.2015.01.029_bib0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clineuro.2015.01.029_bib0180","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1093\/nar\/gkm013","article-title":"Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation","volume":"35","author":"Wojdacz","year":"2007","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846715000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846715000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T14:43:53Z","timestamp":1566312233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846715000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":18,"alternative-id":["S0303846715000591"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2015.01.029","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2015.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}